Treatment outcomes in a safety observational study of dihydroartemisinin/piperaquine (Eurartesim(®)) in the treatment of uncomplicated malaria at public health facilities in four African countries

BACKGROUND: Dihydroartemisinin-piperaquine (DHA-PQ) is one of five WHO recommended artemisinin combination therapy (ACT) for the treatment of uncomplicated malaria. However, little was known on its post-registration safety and effectiveness in sub-Saharan Africa. DHA-PQ provides a long post-treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Adjei, Alexander, Narh-Bana, Solomon, Amu, Alberta, Kukula, Vida, Nagai, Richard Afedi, Owusu-Agyei, Seth, Oduro, Abraham, Macete, Eusebio, Abdulla, Salim, Halidou, Tinto, Sie, Ali, Osei, Isaac, Sevene, Esperance, Asante, Kwaku-Poku, Mulokozi, Abdunoor, Compaore, Guillaume, Valea, Innocent, Adjuik, Martin, Baiden, Rita, Ogutu, Bernhards, Binka, Fred, Gyapong, Margaret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729128/
https://www.ncbi.nlm.nih.gov/pubmed/26818128
http://dx.doi.org/10.1186/s12936-016-1099-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729128/
https://www.ncbi.nlm.nih.gov/pubmed/26818128
http://dx.doi.org/10.1186/s12936-016-1099-7

Ejemplares similares